Trial Search Results

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

The purpose of this extended study is to collect confirmatory safety and effectiveness data on the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in the treatment of aortoiliac and iliac aneurysms.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Cook Research Incorporated

Stanford Investigator(s):

Intervention(s):

  • Device: Zenith® Branch Endovascular Graft-Iliac Bifurcation,

Eligibility


Inclusion Criteria:

   - An aortoiliac or iliac aneurysm of appropriate size

   - Unsuitable distal sealing site for a traditional Zenith® iliac leg graft within the
   common iliac artery

Exclusion Criteria:

   - Less than 18 years of age

   - Inability or refusal to give informed consent

   - Disease considerations that would compromise patient safety or study outcomes

   - Unsuitable arterial anatomy

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Recruiting